Curis Lifesciences
add_icon

Curis Lifesciences

100.95
0.00
(0.00%)
Market Cap
81.61 Cr
PE Ratio
15.23
Volume
0.00
Day High - Low
- - -
52W High-Low
147.90 - 83.60
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
81.61 Cr
EPS
10.26
PE Ratio
15.23
PB Ratio
2.18
Book Value
58.57
EBITDA
11.12
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
37.62
Debt to Equity
1.48
Forecast For
Actual

Company News

View All News
Caret
neutral
Chand Rameshbhai Kanabar resigns as Independent Director from Curis Lifesciences effective July 3, 2026, citing increased professional commitments.
negative
Curis Lifesciences received a fine of Rs 5,900 from NSE for delayed compliance with Regulation 23(9) for the year ended March 2026.
neutral
Promoters of Curis Lifesciences declared no new encumbrances on shares for FY26. The disclosure was made under SEBI Takeover Regulations.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,932.80
#1 4,63,743.46
40.11
#1 61,673.90
12.69
#1 11,565
25.80
64.42
6,953.50
1,84,593.58
71.68
10,560.00
8.73
2,520
13.44
62.61
4,982.40
1,68,627.06
78.32
13,886.20
20.34
2,138
-26.91
78.08
1,441.50
1,16,450.90
29.85
29,044.60
2.24
3,870
-55.32
51.98
1,136.80
1,14,388.68
22.02
27,657.90
17.64
5,026
7.82
58.18
2,492.40
1,13,960.64
#1 21.32
27,487.50
19.98
5,345
#1 87.72
67.70
2,516.70
1,03,938.70
53.47
14,277.60
12.03
1,750
31.75
55.47
1,241.70
1,03,640.86
24.79
35,058.60
3.90
4,158
-86.05
34.07
1,564.00
89,989.10
25.69
33,384.70
3.21
3,376
1.99
54.05
1,558.20
84,120.45
94.51
6,867.80
#1 22.01
890
21.18
66.92
Growth Rate
Revenue Growth
22.24 %
Net Income Growth
13.61 %
Cash Flow Change
-728.57 %
ROE
-60.11 %
ROCE
-29.27 %
EBITDA Margin (Avg.)
-9.78 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Revenue
9
Expenses
6
EBITDA
3
Operating Profit %
30 %
Depreciation
0
Interest
0
Profit Before Tax
2
Tax
1
Net Profit
1
EPS in ₹
24.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
2026
Total Assets
27
30
34
43
82
Fixed Assets
12
12
12
11
12
Current Assets
15
17
22
31
69
Capital Work in Progress
0
0
0
0
1
Investments
0
0
0
0
34
Other Assets
15
18
22
32
0
Total Equity & Liabilities
27
30
34
43
82
Current Liabilities
16
19
19
18
27
Non Current Liabilities
13
10
10
9
7
Total Equity
-1
0
6
16
47
Reserve & Surplus
-1
-0
5
10
39
Share Capital
1
1
1
6
8

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
0
0
-0
Investing Activities
-0
-1
-0
0
Operating Activities
5
3
0
-2
Financing Activities
-5
-3
0
2

Share Holding

% Holding
Dec 2024
Jun 2025
Oct 2025
Nov 2025
Mar 2026
Promoter
92.68 %
92.68 %
92.68 %
68.03 %
68.03 %
FIIs
0.00 %
0.00 %
0.00 %
2.93 %
1.19 %
DIIs
0.00 %
0.00 %
0.00 %
10.86 %
5.80 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
4.37 %
0.00 %
0.00 %
13.97 %
14.38 %
Others
2.95 %
7.32 %
7.32 %
4.20 %
10.60 %
No of Share Holders
27
35
36
36
340

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
04 Dec 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Dec 2025 131.30 119.10
30 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2026 122.00 118.00

Technical Indicators

RSI(14)
Neutral
32.14
ATR(14)
Volatile
2.17
STOCH(9,6)
Neutral
20.50
STOCH RSI(14)
Neutral
32.94
MACD(12,26)
Bearish
-0.17
ADX(14)
Strong Trend
25.58
UO(9)
Bearish
50.97
ROC(12)
Downtrend And Accelerating
-7.47
WillR(14)
Neutral
-78.85